Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patents and patients with Type 2 diabetes

• 收藏
• 分享

专利权人:

Aventis Pharmaceuticals Inc.

发明人:

Rosskamp, Ralf,Gerstein, Hertzel

申请号：

AU2010202738

公开号：

AU2010202738B2

申请日:

2010.06.30

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

#$%^&*AU2010202738B220131205.pdf#####ABSTRACT This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic of Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic of Type 2 Diabetes patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/